
Vertebroplasty And Kyphoplasty Market Report 2026
Global Outlook – By Product Type (Kyphoplasty Devices, Vertebroplasty Devices), By Surgery Type (Vertebroplastic Surgery, Kyphoplastic Surgery), By End User (Hospitals, Ambulatory Surgical Centers) - Market Size, Trends, And Global Forecast 2026-2035
Vertebroplasty And Kyphoplasty Market Overview
• Vertebroplasty And Kyphoplasty market size has reached to $1.04 billion in 2025 • Expected to grow to $1.35 billion in 2030 at a compound annual growth rate (CAGR) of 5.3% • Growth Driver: Surge in Sports-Related Spinal Injuries Fuels Growth of Vertebroplasty and Kyphoplasty • Market Trend: Strategic Partnerships Drive Innovation In Vertebroplasty And Kyphoplasty Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Vertebroplasty And Kyphoplasty Market?
Vertebroplasty and kyphoplasty are minimally invasive surgical procedures used to treat non-healing vertebral compression fractures (VCFs) in the spine. These methods involve the injection of polymethyl methacrylate (PMMA) into the vertebral body for structural reinforcement. The main products of vertebroplasty and kyphoplasty are kyphoplasty devices, vertebroplasty devices. Kyphoplasty devices are specialized medical instruments and tools designed for use in kyphoplasty procedures. They are used in vertebroplastic surgery, kyphoplastic surgery by hospitals and ambulatory surgical centers.
What Is The Vertebroplasty And Kyphoplasty Market Size and Share 2026?
The vertebroplasty and kyphoplasty market size has grown strongly in recent years. It will grow from $1.04 billion in 2025 to $1.1 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing incidence of osteoporotic fractures, aging population growth, rising diagnosis of vertebral compression fractures, expansion of spinal intervention capabilities, improved access to imaging technologies.What Is The Vertebroplasty And Kyphoplasty Market Growth Forecast?
The vertebroplasty and kyphoplasty market size is expected to see strong growth in the next few years. It will grow to $1.35 billion in 2030 at a compound annual growth rate (CAGR) of 5.3%. The growth in the forecast period can be attributed to increasing adoption of outpatient spine procedures, growing demand for rapid pain relief treatments, expansion of advanced spinal biomaterials, rising investments in minimally invasive devices, increasing focus on faster patient recovery. Major trends in the forecast period include increasing adoption of minimally invasive spine procedures, rising use of balloon kyphoplasty devices, growing demand for image-guided interventions, expansion of outpatient spine treatment settings, improved bone cement delivery technologies.Global Vertebroplasty And Kyphoplasty Market Segmentation
1) By Product Type: Kyphoplasty Devices, Vertebroplasty Devices 2) By Surgery Type: Vertebroplastic Surgery, Kyphoplastic Surgery 3) By End User: Hospitals, Ambulatory Surgical Centers Subsegments: 1) By Kyphoplasty Devices: Balloon Kyphoplasty Devices, Inflation Devices, Vertebral Restoration Devices 2) By Vertebroplasty Devices: Bone Cement Delivery Systems, Cannulas and NeedlesWhat Is The Driver Of The Vertebroplasty And Kyphoplasty Market?
The rise in the incidence of spinal injuries related to sports injuries is expected to propel the growth of the vertebroplasty and kyphoplasty markets going forward. Spinal injuries related to sports injuries are damage to the spine that occurs as a result of participating in sports or other physical activities. The surge in sports-related spinal injuries encompasses conditions such as vertebral compression fractures, spondylolisthesis, and herniated discs that require minimally invasive treatment options such as vertebroplasty and kyphoplasty procedures, involving the injection of bone cement into damaged vertebrae. For instance, in 2024, according to the National Spinal Cord Injury Statistical Center (NSCISC), a US-based nonprofit research registry, approximately 305,000 persons (range 257,000–388,000) are living with traumatic spinal cord injury (tSCI) in the United States, and the annual incidence remains about 18,000 new tSCI cases per year. Therefore, the rise in the incidence of spinal injuries related to sports injuries will drive the growth of the vertebroplasty and kyphoplasty industry.Key Players In The Global Vertebroplasty And Kyphoplasty Market
Major companies operating in the vertebroplasty and kyphoplasty market are Cardinal Health, Johnson and Johnson (DePuy Synthes), Medtronic Plc., Stryker Corporation, GS Solutions Inc., Lepu Medical Technology (Beijing)Co.Ltd., Merit Medical Systems Inc., Globus Medical Inc., Alphatec Spine Inc., Rontis Corporation, Spectrum Plastics Group., SOMATEX Medical Technologies GmbH, Zavation LLC, MJ Surgical, Benvenue Medical, Joimax GmbH, Laurane Medical LLC, Spine Wave Inc., G21 S.r.l., BM Korea Co. LTD, Teknimed, Joline GmbH And Co. KG, SCW Medicath Ltd., Stöckli Medical AG, Jiangsu ChangMei Medtech Co.Ltd., IZI Medical ProductsGlobal Vertebroplasty And Kyphoplasty Market Trends and Insights
Major companies operating in the vertebroplasty and kyphoplasty market are adopting a strategic partnership approach to provide the unipedicular balloon catheter for the treatment of compression fractures of the vertebrae. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in June 2024, Medtronic Plc, an Ireland-based medical technology company, partnered with Merit Medical Systems Inc. a US-based medical device company. As a result of this partnership, a unipedicular, steerable balloon catheter will be developed for the treatment of vertebral compression fractures (VCF) in the United States. This agreement builds on the existing collaboration between Medtronic and Merit, with Merit already providing Medtronic's Kyphon Xpander Inflation Syringes for balloon kyphoplasty procedures. The Kyphon KyphoFlex is engineered to enable controlled, precise, and targeted cavity creation during vertebral augmentation. The introduction of this unipedicular solution will complement Medtronic’s current bipedicular balloon kyphoplasty offering, enhancing flexibility and options for clinicians.What Are Latest Mergers And Acquisitions In The Vertebroplasty And Kyphoplasty Market?
In September 2023, Globus Medical Inc., a US-based musculoskeletal solutions company, merged with NuVasive Inc. for an undisclosed amount. Through this merger, Globus Medical aims to enhance its spine and orthopedic portfolio by integrating NuVasive’s advanced minimally invasive spinal surgery systems, enabling technologies, and vertebral stabilization solutions that support procedures related to vertebral compression fractures and spinal deformities. NuVasive Inc. is a US-based medical technology company specializing in innovative spinal surgery platforms used in the treatment of complex spinal conditions.Regional Outlook
North America was the largest region in the vertebroplasty and kyphoplasty market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Vertebroplasty And Kyphoplasty Market?
The vertebroplasty and kyphoplasty market consists of revenues earned by entities through services such as diagnostic evaluation services, consultations, post-operative care, and monitoring services to assist individuals with vertebral compression fractures and related conditions. The vertebroplasty and kyphoplasty market also includes sales of medical imaging equipment, pain management devices, and patient monitoring equipment that help in diagnosis, pain relief, and comprehensive patient care during and after procedures. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Vertebroplasty And Kyphoplasty Market Report 2026?
The vertebroplasty and kyphoplasty market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the vertebroplasty and kyphoplasty industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Vertebroplasty And Kyphoplasty Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $1.1 billion |
| Revenue Forecast In 2035 | $1.35 billion |
| Growth Rate | CAGR of 5.8% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product Type, Surgery Type, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Cardinal Health, Johnson and Johnson (DePuy Synthes), Medtronic Plc., Stryker Corporation, GS Solutions Inc., Lepu Medical Technology (Beijing)Co.Ltd., Merit Medical Systems Inc., Globus Medical Inc., Alphatec Spine Inc., Rontis Corporation, Spectrum Plastics Group., SOMATEX Medical Technologies GmbH, Zavation LLC, MJ Surgical, Benvenue Medical, Joimax GmbH, Laurane Medical LLC, Spine Wave Inc., G21 S.r.l., BM Korea Co. LTD, Teknimed, Joline GmbH And Co. KG, SCW Medicath Ltd., Stöckli Medical AG, Jiangsu ChangMei Medtech Co.Ltd., IZI Medical Products |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
